drugset / Trial / NCT00161083
UDCA for Symptomatic Gallstone Disease
Phase 4
Completed
180 enrolled
UMC Utrecht
Agis Zorgverzekeringen · collabDr. Falk Pharma GmbH · collabDutch Digestive Diseases Foundation · collabZonMw: The Netherlands Organisation for Health Research and Development · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
We conduct a randomized, double-blind, placebo-controlled trial on effects of UDCA on biliary pain and complications in highly symptomatic gallstone patients scheduled for cholecystectomy. We also evaluate potential beneficial effects of impaired gallbladder motility
Timeline
- Start
- 2001-11
- Primary completion
- —
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ursodeoxycholic Acid | Small molecule | — | — |